Skip to main content

Table 1 Intrahepatic recurrence details

From: Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor

Recurrence event

Interval after primary hepatectomy (months)

Recurrence site (size)

Treatment

Serum CA 19-9 level (U/ml)

Serum CEA level (ng/ml)

1

12

S4 (8 mm), S4 (9 mm), S4 (26 mm)

S4 partial resection

32

2.8

2

22

S2 (15 mm), S4 (6 mm)

RFA

25

2.9

3

26

S2 (22 mm)

RFA

29

2.9

4

34

S1 (16 mm), S3 (10 mm)

RFA

35

3.4

5

36

S1 (10 mm)

RFA

29

2.7

6

41

S3 (7 mm), S3 (7 mm)

RFA

29

3.6

7

43

S3 (10 mm)

RFA

26

2.9

8

55

S2 (12 mm)

RFA

32

3.8

  1. RFA radiofrequency ablation, CA 19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen